Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 25 November 2021

Date: 25/11/2021
Location: Online

This extraordinary meeting is organised to discuss the evaluation of an application to extend the use of Comirnaty, a vaccine for COVID-19 developed by BioNTech and Pfizer, to include children aged 5 to 11.

EMA will communicate on the outcome of the meeting. 

The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the European Medicines Agency's opinions on all questions concerning human medicines.

Related content

How useful was this page?

Add your rating
16 ratings
1 rating
1 rating